Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

158 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prophylaxis and treatment of peritoneal carcinomatosis of gastric origin using hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis of randomized trials.
Stefano M, Perrina D, Vallicelli C, Ansaloni L, Fugazzola P, Coccolini F, Agnoletti V, Frassineti GL, Passardi A, Tamberi S, Framarini M, Tassinari D, Matteucci L, Sturaro C, Gallo G, Catena F. Stefano M, et al. Among authors: frassineti gl. J Gastrointest Surg. 2024 Apr 8:S1091-255X(24)00408-6. doi: 10.1016/j.gassur.2024.04.007. Online ahead of print. J Gastrointest Surg. 2024. PMID: 38599315 Review.
Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study.
Solaini L, D'Acapito F, Passardi A, Framarini M, Tauceri F, Di Pietrantonio D, Frassineti GL, Casadei Gardini A, Cucchetti A, Cavaliere D, Ercolani G. Solaini L, et al. Among authors: frassineti gl. World J Surg Oncol. 2019 Mar 27;17(1):58. doi: 10.1186/s12957-019-1602-z. World J Surg Oncol. 2019. PMID: 30917826 Free PMC article.
Conversion Surgery in Gastric Cancer Carcinomatosis.
Morgagni P, Solaini L, Saragoni L, Monti M, Valgiusti M, Vittimberga G, Frassineti GL, Framarini M, Ercolani G. Morgagni P, et al. Among authors: frassineti gl. Front Oncol. 2022 Mar 8;12:852559. doi: 10.3389/fonc.2022.852559. eCollection 2022. Front Oncol. 2022. PMID: 35356199 Free PMC article.
Impact of Pre-Treatment Lactate Dehydrogenase Levels on Prognosis and Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer.
Passardi A, Scarpi E, Tamberi S, Cavanna L, Tassinari D, Fontana A, Pini S, Bernardini I, Accettura C, Ulivi P, Frassineti GL, Amadori D. Passardi A, et al. Among authors: frassineti gl. PLoS One. 2015 Aug 5;10(8):e0134732. doi: 10.1371/journal.pone.0134732. eCollection 2015. PLoS One. 2015. PMID: 26244985 Free PMC article. Clinical Trial.
eNOS polymorphisms as predictors of efficacy of bevacizumab-based chemotherapy in metastatic colorectal cancer: data from a randomized clinical trial.
Ulivi P, Scarpi E, Passardi A, Marisi G, Calistri D, Zoli W, Del Re M, Frassineti GL, Tassinari D, Tamberi S, Vertogen B, Amadori D. Ulivi P, et al. Among authors: frassineti gl. J Transl Med. 2015 Aug 11;13:258. doi: 10.1186/s12967-015-0619-5. J Transl Med. 2015. PMID: 26259598 Free PMC article. Clinical Trial.
Prognostic role of aspartate aminotransferase-lymphocyte ratio index in patients with metastatic colorectal cancer: results from the randomized ITACa trial.
Casadei Gardini A, Scarpi E, Orlandi E, Tassinari D, Leo S, Bernardini I, Gelsomino F, Tamberi S, Ruscelli S, Vespignani R, Ronconi S, Frassineti GL, Amadori D, Passardi A. Casadei Gardini A, et al. Among authors: frassineti gl. Onco Targets Ther. 2018 Aug 29;11:5261-5268. doi: 10.2147/OTT.S166614. eCollection 2018. Onco Targets Ther. 2018. PMID: 30214231 Free PMC article.
Effectiveness of bevacizumab in first- and second-line treatment for metastatic colorectal cancer: ITACa randomized trial.
Petracci E, Scarpi E, Passardi A, Biggeri A, Milandri C, Vecchia S, Gelsomino F, Tassinari D, Tamberi S, Bernardini I, Accettura C, Frassineti GL, Amadori D, Nanni O. Petracci E, et al. Among authors: frassineti gl. Ther Adv Med Oncol. 2020 Jul 23;12:1758835920937427. doi: 10.1177/1758835920937427. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32754229 Free PMC article.
Effectiveness of bevacizumab added to standard chemotherapy in metastatic colorectal cancer: final results for first-line treatment from the ITACa randomized clinical trial.
Passardi A, Nanni O, Tassinari D, Turci D, Cavanna L, Fontana A, Ruscelli S, Mucciarini C, Lorusso V, Ragazzini A, Frassineti GL, Amadori D. Passardi A, et al. Among authors: frassineti gl. Ann Oncol. 2015 Jun;26(6):1201-1207. doi: 10.1093/annonc/mdv130. Epub 2015 Mar 3. Ann Oncol. 2015. PMID: 25735317 Free article. Clinical Trial.
Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer.
Passardi A, Scarpi E, Cavanna L, Dall'Agata M, Tassinari D, Leo S, Bernardini I, Gelsomino F, Tamberi S, Brandes AA, Tenti E, Vespignani R, Frassineti GL, Amadori D, De Giorgi U. Passardi A, et al. Among authors: frassineti gl. Oncotarget. 2016 May 31;7(22):33210-9. doi: 10.18632/oncotarget.8901. Oncotarget. 2016. PMID: 27120807 Free PMC article. Clinical Trial.
158 results